Davidson Michael H.insider trades

In SEC Form 4 filings, Davidson Michael H. is listed as Chief Executive Officer of NewAmsterdam Pharma Co N.V. (NAMS). In the last 90 days, Davidson Michael H. bought $226.5K of NewAmsterdam Pharma Co N.V. (NAMS) on the open market and sold none. The purchase was $226.5K of NewAmsterdam Pharma Co N.V. (NAMS) on Sep 14.

Companies and roles

Company	Role	Transactions	Last filed
NAMSNewAmsterdam Pharma Co N.V.	Chief Executive Officer	1	Sep 15

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-09-15

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
NAMSNewAmsterdam Pharma Co N.V.	Sep 14	Sep 15	P	10,000	$22.65	Purchase +$226,500	792,923	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.